Treatment of stress urinary incontinence with adipose tissue-derived stem cells. - Wikidata - wikimedia - TriplyDB

Treatment of stress urinary incontinence with adipose tissue-derived stem cells.

Treatment of stress urinary incontinence with adipose tissue-derived stem cells.

http://www.wikidata.org/entity/Q33856455

about

Stem Cell Therapy for Treatment of Stress Urinary Incontinence: The Current Status and Challenges Stem cell therapy for incontinence: where are we now? What is the realistic potential?Stem cells as drug delivery methods: application of stem cell secretome for regeneration Stem cell applications for pathologies of the urinary bladder Functional outcome after anal sphincter injury and treatment with mesenchymal stem cells.Cell-based therapy for urinary incontinence.Autologous adipose stem cells in treatment of female stress urinary incontinence: results of a pilot study.The effect of adipose-derived stem cells on augmentation ileocystoplasty: A pilot study.Stress incontinence in the era of regenerative medicine: reviewing the importance of the pudendal nerve.Expression of a Distinct Set of Chemokine Receptors in Adipose Tissue-Derived Stem Cells is Responsible for In Vitro Migration Toward Chemokines Appearing in the Major Pelvic Ganglion Following Cavernous Nerve Injury.Postpartum stress urinary incontinence: lessons from animal models Intra-articular transplantation of porcine adipose-derived stem cells for the treatment of canine osteoarthritis: A pilot study.Myogenic potential of whole bone marrow mesenchymal stem cells in vitro and in vivo for usage in urinary incontinence.Stem cells for the treatment of urinary incontinence.Urine-derived stem cells: A novel and versatile progenitor source for cell-based therapy and regenerative medicine.In vivo imaging of adipose-derived mesenchymal stem cells in female nude mice after simulated childbirth injury.The potential role of stem cells in the treatment of urinary incontinence.Advances in stem cell therapy for the lower urinary tract.The dose-effect safety profile of skeletal muscle precursor cell therapy in a dog model of intrinsic urinary sphincter deficiency.Pelvic organ distribution of mesenchymal stem cells injected intravenously after simulated childbirth injury in female rats.Prospects of stem cell treatment in benign urological diseases.Towards a Treatment of Stress Urinary Incontinence: Application of Mesenchymal Stromal Cells for Regeneration of the Sphincter Muscle.Rat mesenchymal stem cell secretome promotes elastogenesis and facilitates recovery from simulated childbirth injury Label retaining and stem cell marker expression in the developing rat urinary bladder.Stem cell therapy for stress urinary incontinence: a critical review.Male stress urinary incontinence: a review of surgical treatment options and outcomes.Will we ever use stem cells for the treatment of SUI? ICI-RS 2011.Case series of lipid accumulation in the human corpus cavernosum.Association of 17-β Estradiol with Adipose-Derived Stem Cells: New Strategy to Produce Functional Myogenic Differentiated Cells with a Nano-Scaffold for Tissue Engineering.Skeletal myogenic differentiation of urine-derived stem cells and angiogenesis using microbeads loaded with growth factors Tracking intracavernously injected adipose-derived stem cells to bone marrow.Adipose tissue-derived stem cells secrete CXCL5 cytokine with chemoattractant and angiogenic properties.Effects of EdU labeling on mesenchymal stem cells Effects of birth trauma and estrogen on urethral elastic fibers and elastin expression Small activating RNA induces myogenic differentiation of rat adipose-derived stem cells by upregulating MyoD.Smooth Muscle Precursor Cells Derived from Human Pluripotent Stem Cells for Treatment of Stress Urinary Incontinence.Reprogramming of fibroblasts from older women with pelvic floor disorders alters cellular behavior associated with donor age.Mesenchymal stem cell therapy in a rat model of birth-trauma injury: functional improvements and biodistribution In vitro differentiation of endometrial regenerative cells into smooth muscle cells: Α potential approach for the management of pelvic organ prolapse Adipose-Derived Regenerative Cell Injection Therapy for Postprostatectomy Incontinence: A Phase I Clinical Study.

P2860

Q26765866-7F755631-AFEC-4480-A68F-609764D9F015 Q26827498-5F6DAF1C-0EDD-4840-9F98-DDFDE6553AC0 Q26862657-30D22CC1-5AD1-4B2A-A984-5F67F7BA5B82 Q28085228-B2A20567-F549-41D2-A085-5FDF8C48F7EE Q33690001-837D631D-A254-4C83-8776-90DEF7B3FE64 Q33792864-6FB46E5A-AA47-4E10-A62B-76C6ACD55D2E Q33975606-448312FE-0DE9-4EC4-830A-5FAE5FCDB48C Q34114672-592C1FA3-1195-4C8D-B6E8-922EE1C8BBED Q34154320-8AAF16A0-C1F7-4B6A-BF20-2657C2559584 Q34286884-CBB09812-B9F3-4AC8-8D0E-AA3888679EA3 Q34339565-226CC230-AB9B-46B6-881A-AA78293FF3F7 Q34397392-C94DD9AC-E621-4FE1-A951-6D4570316992 Q34429321-736EC1E0-4AA9-47B6-BA48-C0A6E360299B Q34491806-82E35E6A-B260-4A66-B0C8-4C8BC9E42F11 Q34523235-656C7E3D-3897-4B42-963E-644221CE682D Q34795515-933DEF81-A091-4E9A-A907-C9E33FE9C7DC Q34961830-B3544E4D-1848-415D-A3BB-132E72F49457 Q34992259-1C60E3FB-717D-4260-9460-1F2B412ADCA3 Q35119662-BEB7B380-8306-493A-ABE1-EE5AF67D08BB Q35224669-CCE992C5-ED59-4620-9BC9-A24C65B138E1 Q35348849-D7437069-6E81-417B-9B78-3DFFBCD5AED0 Q35667215-7E548218-73EF-441D-BD0F-2FFED7BA4C01 Q35730414-2DB97DEA-05D7-4A53-B733-62BF9D618EE6 Q35803170-7C5866C4-05DB-414F-9418-E66EC85A8FC5 Q35861733-DFFFE968-3342-4922-BB54-A0C249048CF4 Q35974852-F6360D4C-171A-4176-BFE7-AE47B3F82C4C Q35992681-3BB6560F-C5D2-443E-89FF-0E17D65A5DB2 Q36152422-6E43B541-D136-442C-9EC0-04C520D778BA Q36175113-D632BC9B-9171-4329-B066-DC5B87A4DDA2 Q36443867-2030252E-6A20-4518-B7ED-C9992696B714 Q36450951-537F64CF-A48A-4786-B91E-D2D43BFE397B Q36489479-33E6366E-C15C-40EB-939E-FD53A97B6641 Q36503044-7F02661D-3821-4876-A0C4-7296E20A9806 Q36541324-1FB57CFC-84FE-4BFF-AD5F-A9CA6A888284 Q36589394-15F7D345-296E-4233-9218-DC434450075B Q36758712-7375F0A1-FDB4-4CDE-8211-2F4EF6591D18 Q36861744-CEAF1223-E08C-4FF8-A377-4AF71DEE7A0B Q36961112-569BE3BB-FB81-482C-BB6C-69BCE8EAAEBE Q36983831-6B7BA7D1-C063-4A14-84F7-6EFB743827EC Q37124789-CCEAE675-6F20-4B21-B496-40F527D40299

P2860

Treatment of stress urinary incontinence with adipose tissue-derived stem cells.

http://www.wikidata.org/entity/Q33856455

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Treatment of stress urinary incontinence with adipose tissue-derived stem cells.

@ast

Treatment of stress urinary incontinence with adipose tissue-derived stem cells.

@en

type

label

Treatment of stress urinary incontinence with adipose tissue-derived stem cells.

@ast

Treatment of stress urinary incontinence with adipose tissue-derived stem cells.

@en

prefLabel

Treatment of stress urinary incontinence with adipose tissue-derived stem cells.

@ast

Treatment of stress urinary incontinence with adipose tissue-derived stem cells.

@en

P1433

Q33856455-EBE54C80-C487-4C38-BFE9-15F7BD7F280F

P1476

Q33856455-CD0F8AE3-5011-4A54-A7C9-309ABB17EF60

P2093

Q33856455-087C85F9-DDFF-40DE-A18B-592FFE8FB985

Q33856455-50C36419-D510-4CAE-95E0-02A6C1BD5490

Q33856455-851CA315-84D4-4274-9AA0-2E1C5DA95676

Q33856455-8FDB59E2-ACDC-4239-89BA-646A8616A86E

Q33856455-92347445-21FB-4790-98CD-B8A938733B6F

Q33856455-93CCE106-C64A-4933-B76B-460D2331908D

Q33856455-9FE1A97D-E2E4-4AAC-963D-8C4B360E6C9A

Q33856455-E14499BC-578E-4A19-82A0-68415B45FBE6

P2860

Q33856455-0C072886-B0F2-4E6D-9A66-2639D958DA35

Q33856455-0DF29A70-97D1-44BA-837D-F173A2EB0FCC

Q33856455-109AAB35-301D-48EA-B329-A4FFBC5D1E0F

Q33856455-15AC895A-6C1A-4907-80E7-BA6B5BC496D7

Q33856455-1A361033-7FA3-490E-BBEF-976EA36A3626

Q33856455-2221B5B5-FE92-4ED1-82F1-7E9D3798860C

Q33856455-27B77E82-D16D-48C8-BECE-7F670A1EF205

Q33856455-37BBE2B2-0FC1-4F8E-AD9E-14D1C285CCD7

Q33856455-506A86E6-F8BC-4F11-A0B3-C89648ECBA2C

Q33856455-545EFE61-76DE-4945-B182-C13C513B1DF7

P304

Q33856455-5E730A24-5A14-4E8B-8006-ECB9F39EA3F3

P31

Q33856455-08BF8D3F-A565-49DF-884E-F78188545EBA

P356

Q33856455-97592EE0-18F7-4BAC-BF25-F05B9C444EBE

P433

Q33856455-6F6E68D1-2DB2-485A-846A-91307691C162

P478

Q33856455-319E7CF5-E9CA-49A5-B11E-54BC7331B3B2

P577

Q33856455-B9110BEC-F7DE-4202-AF8F-9FE9AAF7C436

P5875

Q33856455-13283617-D5B1-4692-B075-81BD2F1C32B6

P698

Q33856455-41F5F43B-BF24-452D-8B5B-1C66C70D9C22

P932

Q33856455-A99AC4BA-F0EF-4B07-8249-623D731061B6

P356

14653240903350265

P1433

P1476

Treatment of stress urinary incontinence with adipose tissue-derived stem cells.

@en

P2093

Alan W Shindel

http://www.w3.org/2001/XMLSchema#string

Ching-Shwun Lin

http://www.w3.org/2001/XMLSchema#string

Guifang Wang

http://www.w3.org/2001/XMLSchema#string

Guiting Lin

http://www.w3.org/2001/XMLSchema#string

Hongxiu Ning

http://www.w3.org/2001/XMLSchema#string

Lia Banie

http://www.w3.org/2001/XMLSchema#string

Thomas M Fandel

http://www.w3.org/2001/XMLSchema#string

Tom F Lue

http://www.w3.org/2001/XMLSchema#string

P2860

Adipose-derived stem cells for regenerative medicine

Multilineage cells from human adipose tissue: implications for cell-based therapies

Clonogenic multipotent stem cells in human adipose tissue differentiate into functional smooth muscle cells.

Why are MSCs therapeutic? New data: new insight.

Defining stem and progenitor cells within adipose tissue.

Fibroblast growth factor 2 promotes endothelial differentiation of adipose tissue-derived stem cells.

Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy.

The potential of hormones and selective oestrogen receptor modulators in preventing voiding dysfunction in rats

Molecular mechanisms related to parturition-induced stress urinary incontinence

Neuron-like differentiation of adipose tissue-derived stromal cells and vascular smooth muscle cells.

P304

88-95

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/14653240903350265

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2010-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38056414

http://www.w3.org/2001/XMLSchema#string

P698

19878076

http://www.w3.org/2001/XMLSchema#string

P932

2871776

http://www.w3.org/2001/XMLSchema#string